Mechanistically, Beclin-1 facilitates PP2A mediated degradation of c-Myc, leading to decreased cell division and cancer cell proliferation, indicating that Beclin-1 acts as a haploinsufficiency tumor suppressor gene (TSG) in cancer (Cianfanelli et al., 2015). This evidence concerns the gene BECN1 and cancer.